The GHS-R blocker D-[Lys3] GHRP-6 serves as CCR5 Chemokine receptor antagonist

International Journal of Medical Sciences

Volumn 9, Issue 1, 2012, Pages 51-58

  Patel, Kalpesh ^b   Dixit, Vishwa Deep ^c   Lee, Jun Ho ^a   Kim, Jie Wan ^a   Schaffer, Eric M ^d   Nguyen, Dzung ^e   Taub, Dennis D ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d EDGEWOOD CHEMICAL BIOLOGICAL CENTER   (United States)

^e BIOLEGEND   (United States)

Author keywords

Cancer; CCR5; Ghrelin; GHRP 6; GHS R1a; HIV 1; Inflammation; MIP 1 ; MIP 1 ; RANTES

Indexed keywords

CALCIUM; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE[3 LYSINE]; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; N [4 [[[6,7 DIHYDRO 2 (4 METHYLPHENYL) 5H BENZOCYCLOHEPTEN 8 YL]CARBONYL]AMINO]BENZYL] N,N DIMETHYL 2H TETRAHYDROPYRAN 4 AMINIUM CHLORIDE; RANTES; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIUM MOBILIZATION; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BINDING; SIGNAL TRANSDUCTION; VIRUS ENTRY;

EID: 82055177034     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.9.51     Document Type: Article

References (16)

1. Miyasaka M, Tanaka T: Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 2004, 4:360-370.
2. Balkwill F: Cancer and the chemokine network. Nat Rev Cancer 2004, 4:540-550.
3. Cascieri MA, Springer MS: The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention. Curr Opin Chem Biol 2000, 4:420-427.
4. Castagna A, Biswas P, Beretta A, Lazzarin A: The appealing story of HIV entry inhibitors: from discovery of biological mechanisms to drug development. Drugs 2005, 65:879-904.
5. Lai WH, Huang L, Chen CH: HIV entry inhibitors: progress in development and application. Yao Xue Xue Bao, 2010;45:131-140.
6. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, et al: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.
7. Kojima M, Kangawa K: Ghrelin: structure and function. Physiol Rev 2005, 85:495-522.
8. Smith RG: Development of growth hormone secretagogues. Endocr Rev 2005, 26:346-360.
9. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, Segal RA: A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A 2003, 100:13513-13518.
10. Baba M, Nishimura O, Kanzaki N, Okamoto M, Sawada H, Iizawa Y, Shiraishi M, Aramaki Y, Okonogi K, Ogawa Y, et al: A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc Natl Acad Sci U S A 1999, 96:5698-5703.
11. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986, 233:215-219.
12. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW, Jr., Taub DD: Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004, 114:57-66.
13. Nguyen DH, Taub D: Cholesterol is essential for macrophage inflammatory protein 1 beta binding and conformational integrity of CC chemokine receptor 5. Blood 2002, 99:4298-4306.
14. Campbell DJ, Kim CH, Butcher EC: Chemokines in the systemic organization of immunity. Immunol Rev 2003, 195:58-71.
15. Asakawa A, Inui A, Kaga T, Katsuura G, Fujimiya M, Fujino MA, Kasuga M: Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003, 52:947-952.
16. Kino T, Chrousos GP: AIDS-related insulin resistance and lipodystrophy syndrome. Curr Drug Targets Immune Endocr Metabol Disord 2003, 3:111-117.